IANNONE, LUIGI FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.823
AS - Asia 3.270
EU - Europa 2.121
SA - Sud America 398
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 74
OC - Oceania 51
Totale 9.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.689
CN - Cina 1.127
RU - Federazione Russa 976
SG - Singapore 897
IT - Italia 621
HK - Hong Kong 349
KR - Corea 343
BR - Brasile 299
VN - Vietnam 201
FR - Francia 109
IN - India 93
IE - Irlanda 69
GB - Regno Unito 68
FI - Finlandia 67
BD - Bangladesh 62
DE - Germania 61
CA - Canada 55
MX - Messico 54
AU - Australia 51
ID - Indonesia 50
SE - Svezia 40
AR - Argentina 37
NL - Olanda 29
JP - Giappone 25
CH - Svizzera 22
EC - Ecuador 20
NG - Nigeria 18
BJ - Benin 14
CO - Colombia 14
IQ - Iraq 14
JO - Giordania 14
ZA - Sudafrica 14
PK - Pakistan 13
IR - Iran 10
CL - Cile 9
MA - Marocco 9
PL - Polonia 9
TR - Turchia 9
UA - Ucraina 9
MY - Malesia 8
PH - Filippine 8
EG - Egitto 7
TW - Taiwan 7
ES - Italia 6
JM - Giamaica 6
PE - Perù 6
PT - Portogallo 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AT - Austria 5
BE - Belgio 5
LT - Lituania 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
GT - Guatemala 4
NP - Nepal 4
TH - Thailandia 4
TN - Tunisia 4
VE - Venezuela 4
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HN - Honduras 2
KZ - Kazakistan 2
MK - Macedonia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BH - Bahrain 1
BO - Bolivia 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GI - Gibilterra 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
Totale 9.737
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.043
Singapore 694
Ashburn 555
Hefei 473
Seoul 340
Hong Kong 309
San Jose 249
Beijing 113
Council Bluffs 111
Los Angeles 96
Milan 83
Ho Chi Minh City 69
Moscow 68
Florence 67
Dublin 64
Chicago 61
Lauterbourg 56
The Dalles 56
Kent 55
Rome 52
Buffalo 51
Dallas 46
Helsinki 44
Melbourne 43
Hanoi 41
Phoenix 41
New York 40
Bengaluru 37
Jakarta 34
Munich 26
São Paulo 26
Shanghai 24
Mumbai 23
Paris 23
Altamura 20
Lawrence 20
Abuja 18
West Jordan 18
Lappeenranta 17
London 17
Atlanta 16
Chandler 16
Philadelphia 16
Washington 16
Boardman 15
Coppell 15
Tokyo 15
Cotonou 14
Fontebuona 14
Bologna 13
Boston 13
Gustavo Adolfo Madero 13
Haiphong 13
Seattle 13
Turin 13
Naples 12
Princeton 12
Toronto 12
Brooklyn 11
Orem 11
Rio de Janeiro 11
Salt Lake City 11
Wilmington 11
Bern 10
Houston 10
Montreal 10
Brescia 9
Denver 9
Frankfurt am Main 9
Johannesburg 9
Miano 9
Brasília 8
Guayaquil 8
Lausanne 8
Quito 8
Benito Juarez 7
Catania 7
Gioia Tauro 7
Memphis 7
Modena 7
Nagoya 7
Porto Alegre 7
San Francisco 7
St Louis 7
Sydney 7
Warsaw 7
Bari 6
Buenos Aires 6
Elk Grove Village 6
Fairfield 6
Guangzhou 6
Messina 6
Padua 6
San Diego 6
Turku 6
Yubileyny 6
Baghdad 5
Changsha 5
Chennai 5
Curitiba 5
Totale 5.793
Salva come PNG Salva come JPEG
Nome #
Gut microbiota manipulation as an epilepsy treatment 384
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug-Drug Interactions and Tolerability 313
Clinically relevant drug interactions between statins and antidepressants 311
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score 280
Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series 260
Current status and future perspectives in HER2 positive advanced gastric cancer 216
Appropriate use of generic and branded antiseizure medications in epilepsy: Updated recommendations from the Italian League Against Epilepsy (LICE) 202
Perineural invasion score system and clinical outcomes in resected pancreatic cancer patients 194
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study 192
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ) 184
A real‐world comparison among third‐generation antiseizure medications: Results from the COMPARE study 179
Schwann cell C5aR1 co-opts inflammasome NLRP1 to sustain pain in a mouse model of endometriosis 175
Microbiota-gut brain axis involvement in neuropsychiatric disorders 174
Endometriosis and the diagnosis of different forms of migraine: an association with dysmenorrhoea 173
The microbiota-gut-brain axis and epilepsy from a multidisciplinary perspective: Clinical evidence and technological solutions for improvement of in vitro preclinical models 172
Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment 172
The trpa1 channel amplifies the oxidative stress signal in melanoma 170
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine 168
Tumor-Infiltrating Lymphocyte Recognition in Primary Melanoma by Deep Learning Convolutional Neural Network 167
Non-neuronal TRPA1 encodes mechanical allodynia associated with neurogenic inflammation and partial nerve injury in rats 167
Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine 167
Emerging Pharmacological Treatments for Migraine in the Pediatric Population 164
Spatial Proximity and Relative Distribution of Tumor-Infiltrating Lymphocytes and Macrophages Predict Survival in Melanoma 163
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 160
The Microbiome-Gut-Brain axis regulates social cognition & craving in young binge drinkers 153
The role of TRP ion channels in migraine and headache 152
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) 145
Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox-Gastaut Syndrome 145
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 144
Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs 144
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 142
Can we 'seize' the gut microbiota to treat epilepsy? 140
Antiseizure medications for the prophylaxis of migraine during the anti-CGRP drugs era 138
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 137
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report 137
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 136
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine 135
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? 135
Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system 132
Status epilepticus in pregnancy: a literature review and a protocol proposal 132
Association of anti‐calcitonin gene‐related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study 131
Renal denervation for resistant hypertension 130
COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report 130
Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy 128
Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany 128
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 128
The gut microbiome and efficacy of cancer immunotherapy 127
Migraine Treatment: Towards New Pharmacological Targets 126
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY) 125
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 124
Patterns of anti‐CGRP mAbs use and variation of triptan consumption following treatment initiation: A descriptive drug utilization study in the Tuscany region, Italy 122
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study 121
Ixekizumab May Improve Renal Function in Psoriasis 121
Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine 115
Management of status epilepticus in patients with liver or kidney disease: a narrative review 111
Neuronal and non-neuronal TRPA1 as therapeutic targets for pain and headache relief 109
Gut microbiota and psychogenic non-epileptic seizures: i can feel it in the belly 108
Impact of duration of chronic migraine on long‐term effectiveness of monoclonal antibodies targeting the calcitonin gene‐related peptide pathway—A real‐world study 104
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review 101
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study 100
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a "real world" context: focus on temporal lobe epilepsy 92
The potential role of interventions impacting on gut-microbiota in epilepsy 81
Immunotherapy-related biomarkers: Confirmations and uncertainties 71
Morpho-phenotypic characterization of melanoma brain metastases immune microenvironment: A multicentre retrospective study 36
Totale 9.823
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202274 0 0 0 0 0 0 0 18 15 10 15 16
2022/2023314 13 51 15 9 1 37 35 12 16 29 68 28
2023/2024587 13 31 57 34 39 61 33 136 59 61 50 13
2024/20253.288 92 309 184 418 804 463 124 152 109 191 161 281
2025/20264.634 504 711 795 581 377 144 444 221 204 233 158 262
2026/2027926 289 118 403 116 0 0 0 0 0 0 0 0
Totale 9.823